why choose us

First received: July 6, 2022

Clinical Trial: Azathioprine Linked With Impaired Intestinal Epithelial Postoperative Regeneration in Crohn's Disease

Study Status: Completed

Recruit Status: Completed

Condition: Inflammatory Bowel Diseases

Study Type: Observational


Official Title: Azathioprine Linked With Impaired Intestinal Epithelial Postoperative Regeneration in Crohn's Disease

Brief Summary: What is known?the impact of AZA, immunomodulatory drug widely used in active CD, on the intestinal wall differs from those of steroids, what is reflected in the significant difference in the postoperative anastomotic leaks rateAZA inhibits intestinal epithelial cell growth by inducing the apoptosis and inhibiting proliferation of intestinal epithelial cells in in vitro studies What is new?The effect of AZA on cellular damage was assessed in humans' studyAZA increases cell apoptosis in the intestinal epithelium of…

Read more